[ENTL] Entellus Medical, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 18.91 Change: 0.25 (1.34%)
Ext. hours: Change: 0 (0%)

chart ENTL

Refresh chart

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -6.6% Sales Growth - Q/Q-6.6% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-5.7% ROE-8.01% ROI-6.26%
Current Ratio10.42 Quick Ratio10.12 Long Term Debt/Equity0.23 Debt Ratio0.13
Gross Margin77.87% Operating Margin-15.1% Net Profit Margin-19.8% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities81.12 M Cash From Investing Activities-63.21 M Cash From Operating Activities-1.67 M Gross Profit10.55 M
Net Profit-4.35 M Operating Profit-3.45 M Total Assets97.15 M Total Current Assets90.86 M
Total Current Liabilities8.72 M Total Debt20 M Total Liabilities28.04 M Total Revenue13.5 M
Technical Data
High 52 week24.67 Low 52 week12.04 Last close24.01 Last change-0.04%
RSI45.83 Average true range0.09 Beta0.73 Volume23.08 K
Simple moving average 20 days-0.17% Simple moving average 50 days-0.76% Simple moving average 200 days30.25%
Performance Data
Performance Week-0.33% Performance Month-0.17% Performance Quart50.44% Performance Half38.47%
Performance Year40.57% Performance Year-to-date-1.56% Volatility daily0.21% Volatility weekly0.47%
Volatility monthly0.95% Volatility yearly3.31% Relative Volume146.48% Average Volume353.97 K
New High New Low

News

2018-06-28 16:30:00 | Multi-Center Market Research Confirms Nasal Valve Collapse as a Contributor for Most Nasal Obstruction Sufferers

2018-02-06 08:25:00 | New Research Coverage Highlights Atara Biotherapeutics, SPX, Entellus Medical, Columbus McKinnon, NantKwest, and Merrimack Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations for 2018

2018-01-17 13:24:00 | The Law Offices of Vincent Wong Notifies Investors of a Complaint on Behalf of Entellus Medical, Inc. Shareholders Concerning the Sale of the Company to Stryker Corporation – ENTL

2018-01-08 16:30:00 | ACT NOW: Monteverde & Associates PC Announces An Investigation Of Entellus Medical, Inc. - ENTL

2018-01-03 10:43:03 | Entellus ENTL Nears 52-Week High: What's Driving It?

2017-12-28 15:34:00 | Lifshitz & Miller LLP Announces Investigation of Atlantic Coast Financial Corporation, Bazaarvoice, Inc., Buffalo Wild Wings, Inc., Entellus Medical, Inc., General Cable Corporation, Quality Systems, Inc., and Shopify Inc.

2017-12-28 10:47:00 | INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders - ENTL

2017-12-19 15:15:02 | Stryker Expands with Entellus Acquisition

2017-12-13 15:10:00 | The Law Offices of Vincent Wong Notifies Investors of an Investigation of Entellus Medical, Inc. Concerning the Sale of the Company to Stryker Corporation

2017-12-13 09:44:00 | SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Buffalo Wild Wings, Inc., Aetna, Inc., General Cable Corporation, Sigma Designs, Inc., Entellus Medical, Inc., and Regal Entertainment Group

2017-12-11 17:15:00 | ENTELLUS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Entellus Medical, Inc.

2017-12-08 14:51:00 | INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders

2017-12-08 09:30:00 | ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Entellus Medical, Inc.

2017-12-08 08:13:08 | Is There Now An Opportunity In Entellus Medical Inc ENTL?

2017-12-08 07:15:33 | Entellus Medical, Inc. breached its 50 day moving average in a Bullish Manner : ENTL-US : December 8, 2017

2017-12-07 16:14:00 | ENTELLUS MEDICAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

2017-12-07 13:39:10 | ETFs with exposure to Entellus Medical, Inc. : December 7, 2017

2017-12-07 13:08:00 | Why Entellus Medical Inc. Skyrocketed Higher Today

2017-12-07 13:00:17 | Entellus Medical to be sold to Stryker for $622M

2017-12-07 11:16:00 | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders – ENTL

2017-12-07 08:57:43 | Stryker beefs up ENT business with $662 mln Entellus buy

2017-12-07 08:29:54 | Stryker to buy Entellus Medical for $662 mln

2017-12-07 08:22:14 | Entellus Medical to be acquired by Stryker for $24 a share in cash

2017-12-07 08:17:01 | Stryker announces definitive agreement to acquire Entellus

2017-12-07 08:15:00 | Entellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Share in Cash

2017-11-21 11:41:36 | ETFs with exposure to Entellus Medical, Inc. : November 21, 2017

2017-11-14 16:05:00 | Entellus Medical to Participate in Upcoming Investor Conferences

2017-11-13 10:02:33 | Entellus Medical, Inc. :ENTL-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017

2017-11-13 05:30:00 | Anthem Inc. Issues Positive Coverage Decision for Balloon Sinus Dilation

2017-11-10 12:20:03 | ETFs with exposure to Entellus Medical, Inc. : November 10, 2017

2017-11-02 15:35:26 | Edited Transcript of ENTL earnings conference call or presentation 1-Nov-17 8:30pm GMT

2017-11-01 19:05:48 | Entellus reports 3Q loss

2017-11-01 16:05:00 | Entellus Medical Announces Third Quarter 2017 Financial Results

2017-11-01 09:25:00 | Entellus Medical, Inc. to Host Earnings Call

2017-11-01 07:35:15 | Is Entellus Medical Inc’s ENTL Balance Sheet Strong Enough To Weather A Storm?

2017-10-30 08:30:00 | Entellus Announces Long-Term Data Confirming the Durable Relief of Nasal Obstruction Symptoms with Latera® from Spirox®

2017-10-18 16:05:00 | Entellus Medical to Report Third Quarter 2017 Financial Results November 1, 2017

2017-10-17 09:41:52 | ETFs with exposure to Entellus Medical, Inc. : October 17, 2017

2017-10-06 10:49:53 | ETFs with exposure to Entellus Medical, Inc. : October 6, 2017

2017-10-05 09:36:47 | Entellus Medical, Inc. :ENTL-US: Earnings Analysis: Q2, 2017 By the Numbers : October 5, 2017

2017-09-25 08:09:40 | Entellus Medical, Inc. breached its 50 day moving average in a Bullish Manner : ENTL-US : September 25, 2017

2017-09-14 20:19:16 | Entellus Medical, Inc. – Value Analysis NASDAQ:ENTL : September 15, 2017

2017-09-13 10:12:32 | Entellus Medical, Inc. breached its 50 day moving average in a Bearish Manner : ENTL-US : September 13, 2017

2017-08-08 16:03:00 | Entellus Medical Announces New Employee Inducement Option Grants

2017-08-04 12:41:54 | Edited Transcript of ENTL earnings conference call or presentation 3-Aug-17 8:30pm GMT

2017-08-04 00:19:58 | Entellus reports 2Q loss

2017-08-03 16:03:00 | Entellus Medical Announces Second Quarter 2017 Financial Results

2017-08-03 11:40:00 | Investor Network: Entellus Medical, Inc. to Host Earnings Call

2017-07-26 16:03:00 | Entellus Medical to Present at the Canaccord Genuity Annual Growth Conference

2017-07-20 16:30:00 | Entellus Medical to Report Second Quarter 2017 Financial Results August 3, 2017